Mehra Anand

Aerie Pharmaceuticals, Inc.

Director

Avg. Two Year Performance

119% Avg. Purchase Return 48% Compound

(10%) Avg. Sale Return (5%) Compound

Holdings: 469.59K shares

Last Three Months: 17-Feb-24 -- 16-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

17-May-22 -- 16-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions